{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "7858800",
  "DateCompleted": {
    "Year": "1995",
    "Month": "03",
    "Day": "23"
  },
  "DateRevised": {
    "Year": "2013",
    "Month": "11",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0007-1064",
      "JournalIssue": {
        "Volume": "52",
        "Issue": "10",
        "PubDate": {
          "MedlineDate": "1994 Nov 16-Dec 13"
        }
      },
      "Title": "British journal of hospital medicine",
      "ISOAbbreviation": "Br J Hosp Med"
    },
    "ArticleTitle": "Hazards associated with the recreational drug 'ecstasy'.",
    "Pagination": {
      "StartPage": "507",
      "EndPage": "514",
      "MedlinePgn": "507, 510-4"
    },
    "Abstract": {
      "AbstractText": [
        "The amphetamine analogue 'ecstasy' is a popular 'designer' drug and is perceived by its users to be relatively harmless. However, it has been associated with several fatalities through a disorder of thermoregulation, and severe reactions have been reported across many disciplines. This article emphasises the hazardous nature of the drug and highlights the urgency and nature of treatment in the acutely toxic state."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Surgical and Anaesthetic Sciences, University of Sheffield, Royal Hallamshire Hospital."
          }
        ],
        "LastName": "O'Connor",
        "ForeName": "B",
        "Initials": "B"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Br J Hosp Med",
    "NlmUniqueID": "0171545",
    "ISSNLinking": "0007-1064"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "KE1SEN21RM",
      "NameOfSubstance": "N-Methyl-3,4-methylenedioxyamphetamine"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Diagnosis, Differential"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "chemically induced",
        "diagnosis",
        "therapy"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Infant"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "N-Methyl-3,4-methylenedioxyamphetamine"
    },
    {
      "QualifierName": [
        "complications"
      ],
      "DescriptorName": "Substance-Related Disorders"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Syndrome"
    }
  ],
  "NumberOfReferences": "33"
}